Oncology Central

Genetic test could predict stomach or esophageal cancer relapse

Researchers from the Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust (both London, UK) have identified seven genes that could be linked to the survival outcome of patients diagnosed with stomach or esophageal cancer. Using this information, the team have developed a test that can give crucial information about cancer progression.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.